newsfilter.io

Latest Interviews

Showing 1–3 of 3 transcripts.

Clear all filters
  1. Y Combinator1 min

    Paul Graham: What does it mean to do things that don't scale?

    Paul Graham

    The "doing things that don't scale" philosophy, central to Y Combinator's teachings, advises founders to execute manual, high-effort tasks to acquire early customers despite the method's inherent unsustainability. This approach, championed by co-founder Paul Graham based on his personal experiences, prioritizes gaining critical information about customer needs over efficiency during the initial startup phase. By engaging in these painstaking operations, entrepreneurs mitigate the risk of failing to reach significant scale while building the foundational knowledge required for future growth.

  2. Y Combinator1 min

    Paul Graham: What are some common mistakes founders make?

    Paul Graham

    Many founders avoid validating their isolated visions through user contact due to a fear of rejection or the tedious nature of sales, often delaying product launches until they face humiliating feedback. The speaker argues that the most effective strategy involves identifying individuals willing to pay for a specific solution they personally experience, rather than building based on hypothetical needs. Ultimately, embracing direct engagement with the real world is presented as the only viable path to iteration and product improvement.

  3. Y Combinator2 min

    Paul Graham: When should you launch your startup?

    Paul Graham

    This framework argues that the risk of delaying a product launch exceeds the risk of launching early, establishing the "minimum quantum of utility" as the sole readiness criterion where at least one user gains a new capability. A launch is deemed premature only if no value is derived, while securing ten "super excited" core users, as suggested by Paul Bouquet, satisfies the threshold regardless of broader market indifference. Consequently, the strategy prioritizes deep enthusiasm from a small initial group over broad market approval to validate a product's viability.